Neoadjuvant Chemoradiotherapy Followed by Sequential Immunotherapy for Thoracic Esophageal Squamous Cell Carcinoma

Conditions: Esophageal Squamous Cell Carcinoma Interventions: Drug: paclitaxel; Drug: carboplatin; Drug: tislelizumab; Radiation: radiotherapy Sponsors: Qiu Guoqin Enrolling by invitation

https://clinicaltrials.gov/study/NCT06303583

Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials